67 / 88
HIPERTENSIÓN / 2016 / VOL. 21
67
15. Kumbhani DJ, Bavry Aa Fau - Harvey JE, Harvey Je Fau - de Souza R, et al. Clinical outcomes after percutaneous revascularization
versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials.
16. Textor SC, Lerman L, McKusick M. The Uncertain Value of Renal Artery Interventions: Where Are We Now? JACC: Cardiovascular
Interventions 2009;2:175-82.
17. White CJ. Optimizing Outcomes for Renal Artery Intervention. Circulation: Cardiovascular Interventions 2010;3:184.
18. Jaff MR, Bates M, Sullivan T, et al. Significant reduction in systolic blood pressure following renal artery stenting in patients with
uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv 2012;80:343-50.
19. Chrysant GS, Bates MC, Sullivan TM, et al. Proper patient selection yields significant and sustained reduction in systolic blood
pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial. J
Clin Hypertens (Greenwich) 2014;16:497-503.
20. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation
1998;98:2866-72.
21. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am
1984;11:383-92.
22. Shafique S, Peixoto AJ. Renal artery stenosis and cardiovascular risk. J Clin Hypertens (Greenwich) 2007;9:201-8.
23. Pearce JD, Craven BL, Craven TE, et al. Progression of atherosclerotic renovascular disease: a prospective population-based study.
Journal of Vascular Surgery;44:955-62.
24. Cohen JB, Townsend RR. Use of renin-angiotensin system blockade in patients with renal artery stenosis. Clin J Am Soc Nephrol
2014;9:1149-52.
25. Losito A, Errico R, Santirosi P, Lupattelli T, Scalera GB, Lupattelli L. Long-term follow-up of atherosclerotic renovascular disease.
Beneficial effect of ACE inhibition. Nephrology Dialysis Transplantation 2005;20:1604-9.
26. Weber BR, Dieter RS. Renal artery stenosis: epidemiology and treatment. International Journal of Nephrology and Renovascular
Disease 2014;7:169-81.
27. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease,
incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994;24:622-9.
28. Iglesias JI, Hamburger RJ, Feldman L, Kaufman JS. The natural history of incidental renal artery stenosis in patients with aortoiliac
vascular disease. The American journal of medicine 2000;109:642-7.
29. Finke R Fau - Gross R, Gross R Fau - Hackenthal E, Hackenthal E Fau - Huber J, Huber J Fau - Kirchheim HR, Kirchheim HR.
Threshold pressure for the pressure-dependent renin release in the autoregulating kidney of conscious dogs.
30. De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am
Coll Cardiol 2006;48:1851-5.
31. Krumme B, Mann JF. Atherosclerotic renal artery stenosis in 2001--are we less confused than before? Nephrology, dialysis,
transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16:2124-7.
32. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease
(lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association
for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular
Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee
to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of
Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic
Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006;47:1239-312.
33. Caielli P, Frigo AC, Pengo MF, et al. Treatment of atherosclerotic renovascular hypertension: review of observational studies and a
meta-analysis of randomized clinical trials. Nephrology Dialysis Transplantation 2014.
34. Murphy TP, Cooper CJ, Pencina KM, et al. Relationship of Albuminuria and Renal Artery Stent Outcomes: Results From the CORAL
Randomized Clinical Trial (Cardiovascular Outcomes With Renal Artery Lesions).
35. Simon JF. Stenting atherosclerotic renal arteries: time to be less aggressive. Cleve Clin J Med 2010;77:178-89.
36. Daloul R, Morrison AR. Approach to atherosclerotic renovascular disease: 2016. Clin Kidney J 2016;9:713-21.
37. Raman G, Adam GP, Halladay CW, Langberg VN, Azodo IA, Balk EM. Comparative effectiveness of management strategies for renal
artery stenosis: An updated systematic review. Annals of internal medicine 2016;165:635-49.
38. Radermacher J, Chavan A Fau - Bleck J, Bleck J Fau - Vitzthum A, et al. Use of Doppler ultrasonography to predict the outcome
of therapy for renal-artery stenosis.